Cargando…

Artificially sporulated Escherichia coli cells as a robust cell factory for interfacial biocatalysis

The natural bacterial spores have inspired the development of artificial spores, through coating cells with protective materials, for durable whole-cell catalysis. Despite attractiveness, artificial spores developed to date are generally limited to a few microorganisms with their natural endogenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zhiyong, Hübner, René, Li, Jian, Wu, Changzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170730/
https://www.ncbi.nlm.nih.gov/pubmed/35668090
http://dx.doi.org/10.1038/s41467-022-30915-2
_version_ 1784721500740255744
author Sun, Zhiyong
Hübner, René
Li, Jian
Wu, Changzhu
author_facet Sun, Zhiyong
Hübner, René
Li, Jian
Wu, Changzhu
author_sort Sun, Zhiyong
collection PubMed
description The natural bacterial spores have inspired the development of artificial spores, through coating cells with protective materials, for durable whole-cell catalysis. Despite attractiveness, artificial spores developed to date are generally limited to a few microorganisms with their natural endogenous enzymes, and they have never been explored as a generic platform for widespread synthesis. Here, we report a general approach to designing artificial spores based on Escherichia coli cells with recombinant enzymes. The artificial spores are simply prepared by coating cells with polydopamine, which can withstand UV radiation, heating and organic solvents. Additionally, the protective coating enables living cells to stabilize aqueous-organic emulsions for efficient interfacial biocatalysis ranging from single reactions to multienzyme cascades. Furthermore, the interfacial system can be easily expanded to chemoenzymatic synthesis by combining artificial spores with metal catalysts. Therefore, this artificial-spore-based platform technology is envisioned to lay the foundation for next-generation cell factory engineering.
format Online
Article
Text
id pubmed-9170730
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91707302022-06-08 Artificially sporulated Escherichia coli cells as a robust cell factory for interfacial biocatalysis Sun, Zhiyong Hübner, René Li, Jian Wu, Changzhu Nat Commun Article The natural bacterial spores have inspired the development of artificial spores, through coating cells with protective materials, for durable whole-cell catalysis. Despite attractiveness, artificial spores developed to date are generally limited to a few microorganisms with their natural endogenous enzymes, and they have never been explored as a generic platform for widespread synthesis. Here, we report a general approach to designing artificial spores based on Escherichia coli cells with recombinant enzymes. The artificial spores are simply prepared by coating cells with polydopamine, which can withstand UV radiation, heating and organic solvents. Additionally, the protective coating enables living cells to stabilize aqueous-organic emulsions for efficient interfacial biocatalysis ranging from single reactions to multienzyme cascades. Furthermore, the interfacial system can be easily expanded to chemoenzymatic synthesis by combining artificial spores with metal catalysts. Therefore, this artificial-spore-based platform technology is envisioned to lay the foundation for next-generation cell factory engineering. Nature Publishing Group UK 2022-06-06 /pmc/articles/PMC9170730/ /pubmed/35668090 http://dx.doi.org/10.1038/s41467-022-30915-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Sun, Zhiyong
Hübner, René
Li, Jian
Wu, Changzhu
Artificially sporulated Escherichia coli cells as a robust cell factory for interfacial biocatalysis
title Artificially sporulated Escherichia coli cells as a robust cell factory for interfacial biocatalysis
title_full Artificially sporulated Escherichia coli cells as a robust cell factory for interfacial biocatalysis
title_fullStr Artificially sporulated Escherichia coli cells as a robust cell factory for interfacial biocatalysis
title_full_unstemmed Artificially sporulated Escherichia coli cells as a robust cell factory for interfacial biocatalysis
title_short Artificially sporulated Escherichia coli cells as a robust cell factory for interfacial biocatalysis
title_sort artificially sporulated escherichia coli cells as a robust cell factory for interfacial biocatalysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170730/
https://www.ncbi.nlm.nih.gov/pubmed/35668090
http://dx.doi.org/10.1038/s41467-022-30915-2
work_keys_str_mv AT sunzhiyong artificiallysporulatedescherichiacolicellsasarobustcellfactoryforinterfacialbiocatalysis
AT hubnerrene artificiallysporulatedescherichiacolicellsasarobustcellfactoryforinterfacialbiocatalysis
AT lijian artificiallysporulatedescherichiacolicellsasarobustcellfactoryforinterfacialbiocatalysis
AT wuchangzhu artificiallysporulatedescherichiacolicellsasarobustcellfactoryforinterfacialbiocatalysis